Drugs & Therapy Perspectives

, Volume 17, Issue 5, pp 9–12

Non-nicotine pharmacotherapy may prove useful in smoking cessation

New drugs and disease management
  • 13 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Covey LS, Sullivan MA, Johnston JA, et al. Advances in non-nicotine therapy for smoking cessation. Drugs 2000; 59(1): 17–31PubMedCrossRefGoogle Scholar
  2. 2.
    Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 281: 72–6PubMedCrossRefGoogle Scholar
  3. 3.
    Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 263: 2760–5CrossRefGoogle Scholar
  4. 4.
    Glassman AH, Jackson WK, Walsh BT, et al. Cigarette craving, smoking withdrawal, and clonidine. Science 1984; 226: 864–6PubMedCrossRefGoogle Scholar
  5. 5.
    Gourlay SG, Benowitz NL. Is clonidine an effective smoking cessation therapy? Drugs 1995; 50: 197–207PubMedCrossRefGoogle Scholar
  6. 6.
    Covey LS, Glassman AH. A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation. Br J Addict 1991; 86: 991–8PubMedCrossRefGoogle Scholar
  7. 7.
    Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988; 259: 2863–6PubMedCrossRefGoogle Scholar
  8. 8.
    Benowitz NL, Wilson Peng W. Non-nicotine pharmacotherapy for smoking cessation: mechanisms and prospects. CNS Drugs 2000; 13(4): 265–85CrossRefGoogle Scholar
  9. 9.
    AHFS Drug Information 2000. Bethesda MD: American Society of Health System Pharmacists, Inc., 2000Google Scholar
  10. 10.
    British National Formulary No. 39. London: The Pharmaceutical Press, 2000 MarGoogle Scholar
  11. 11.
    Ferry LH, Robbins AS, Scariati PD, et al. Enhancement of smoking cessation using the antidepressant, bupropion hydrochloride [abstract]. Circulation 1992; 86: I–671Google Scholar
  12. 12.
    Ferry LH, Burchette RJ. Efficacy of bupropion for smoking cessation in non-depressed smokers [abstract]. J Addict Dis 1994; 13: 249Google Scholar
  13. 13.
    Hurt RD, Sachs DL, G’Lover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Eng J Med 1997; 337: 1195–202CrossRefGoogle Scholar
  14. 14.
    Hall SM, Reus VI, Munoz F, et al. Nortriptyline and cognitive behavioural therapy for the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683–90PubMedCrossRefGoogle Scholar
  15. 15.
    Prochazka AV, Weaver MJ, Keller RT, et al. A randomised trial of nortriptyline for smoking cessation. Arch Intern Med 1998; 158: 2035–9PubMedCrossRefGoogle Scholar
  16. 16.
    Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brain of smokers. Nature 1996; 379: 733–6PubMedCrossRefGoogle Scholar
  17. 17.
    Berlin I, Spreux-Varoquaux O, Said S, et al. Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers. Drug Alcohol Depend 1997; 45: 31–7PubMedCrossRefGoogle Scholar
  18. 18.
    Berlin I, Said S, Spreux-Varoquaux O, et al. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Trial Ther 1995; 58: 444–52Google Scholar
  19. 19.
    Houtsmuller EJ, Clemmey PA, Sigler LA, et al. Effects of naltrexone on smoking and abstinence: problems of drug dependence 1996 [abstract]. Problems of drugs dependence. Proceedings of the 58th Annual Scientific Meeting of the College on Problems of Drug Dependence Inc. NIDA Res Monogr 1997; 174: 68Google Scholar
  20. 20.
    Covey LS, Glassman AH, Stetner F. Naltrexone’s effects on short-term and long-term smoking cessation. Addictive Dis 1999; 18: 31–40CrossRefGoogle Scholar
  21. 21.
    Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, nicotine patch or both for smoking cessation. N Eng J Med 1999; 340(9): 685–91CrossRefGoogle Scholar
  22. 22.
    Rose JE, Behm FM, Westman EC, et al. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Trials Ther 1994; 56: 86–9Google Scholar

Copyright information

© Adis International Limited 2001

Personalised recommendations